Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study

Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily increasing incidence and poor prognosis. Ongoing clinical trials are assessing the effectiveness and safety of a few immune checkpoint inhibitors (ICIs) in CCA patients. However, these ICI treatments as monotherapies may...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lu, Prithviraj, Prashanth, Shrestha, Ritu, Sharma, Revati, Anaka, Matthew, Bridle, Kim R., Kannourakis, George, Crawford, Darrell H.G., Jayachandran, Aparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159105/
https://www.ncbi.nlm.nih.gov/pubmed/34069452
http://dx.doi.org/10.3390/jcm10102191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159105/
https://www.ncbi.nlm.nih.gov/pubmed/34069452
http://dx.doi.org/10.3390/jcm10102191

Ejemplares similares